Patient Capital Sees Mid-Teens Earnings Growth at UnitedHealth
Patient Capital says UnitedHealth is early in an earnings recovery and expects mid-teens earnings growth over the next few years.
Key takeaways
- Patient Capital called UnitedHealth an early-stage earnings recovery.
- The strategy expects mid-teens earnings growth over the next few years in most environments.
- UnitedHealth shares were down 0.77% since the previous close Monday afternoon.
Patient Capital Management’s Patient Opportunity Equity Strategy said UnitedHealth Group is early in an earnings recovery and expects earnings to grow at a mid-teens rate over the next few years in most environments. The manager called the company a significant contributor for the year in its Q3 2026 investor letter.
The strategy said it continues to like UnitedHealth’s risk-reward, citing its management team. The growth outlook is the fund manager’s assessment, not a company forecast.
UnitedHealth shares were at $376.37, down 0.77% since the previous close, as of Monday afternoon. The stock closed at $379.30 on October 9, according to the article.
This article was produced with the help of AI technology. Source: Yahoo Finance
